Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis

Company Overview

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Key Stats

• Today's Range: $41.21 to $43.18
• 50-Day Range: $24.40 to $42.85
• 52-Week Range: $16.50 to $43.58
• Volume: 14,635 shs
• Average Volume: 43,415 shs
• Market Capitalization: $3.62 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

AAPG Stock Analysis - Frequently Asked Questions

How have AAPG shares performed this year?

Ascentage Pharma Group International's stock was trading at $18.67 at the beginning of the year. Since then, AAPG stock has increased by 122.3% and is now trading at $41.51.

When did Ascentage Pharma Group International IPO?

Ascentage Pharma Group International (AAPG) raised $126 million in an initial public offering (IPO) on Friday, January 24th 2025. The company issued 7,325,000 shares at $17.25 per share.

When did the company's lock-up period expire?

Ascentage Pharma Group International's lock-up period expired on Wednesday, July 23rd. Ascentage Pharma Group International had issued 7,325,000 shares in its IPO on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Who are Ascentage Pharma Group International's major shareholders?

Ascentage Pharma Group International's top institutional shareholders include Chevy Chase Trust Holdings LLC (0.01%).

How do I buy shares of Ascentage Pharma Group International?

Shares of AAPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AAPG
• Previous Symbol: NASDAQ:AAPG
• CIK: 2023311
• Web: N/A
• Phone: 86 512 8555 7777
• Fax: N/A
• Employees: 600
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 3.24
• Current Ratio: 1.26
• Quick Ratio: 1.26

Sales & Book Value

• Annual Sales: $134.35 million
• Price / Sales: 24.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.48 per share
• Price / Book: 78.33

Miscellaneous

• Outstanding Shares: 87,250,000
• Free Float: N/A
• Market Cap: $3.28 billion
• Optionable: N/A
• Beta: N/A